AUTHOR=Jared Misonge Onyancha , Gervason Apiri Moriasi , James Onsinyo Meroka , Samuel Murigi Wainaina , Geoffrey Ogeto Sengera , Vincent Obaga Nyandoro 

TITLE=Ethnomedicinal uses, phytochemistry, and pharmacology of the genus Sarcophyte: a review 

JOURNAL=Frontiers in Pharmacology

VOLUME=14

YEAR=2024

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1301672

DOI=10.3389/fphar.2023.1301672

ISSN=1663-9812

ABSTRACT=<p>Although medicinal plants have been used by ethnic communities since ancient times to prevent and treat various diseases, only a few have been scientifically documented. Therefore, due to their rare availability and lack of comprehensive scientific information, we reviewed the ethnomedicinal uses, phytochemistry, and pharmacological activities of plants within the genus <italic>Sarcophyte</italic>. To do this, we used specific search terms and phrases to retrieve relevant information from online sources published in English from 2000 to July 2023. The results showed that there are only two plants in the genus <italic>Sarcophyte</italic> (<italic>Sarcophyte sanguinea</italic> Sparrm. and <italic>Sarcophyte piriei</italic> Hutch.), which are traditionally used to treat a wide range of diseases, especially cancer, and skin, gastrointestinal, and urinogenital tract ailments in humans, and to cure animals in ethnoveterinary practices. It was noted that 13 secondary metabolites have been isolated from the two plants, the most prominent of which are flavonoids (diinsininol, diinsinin, and naringenin). The antioxidant activity of <italic>S</italic>. <italic>piriei</italic> is reported based on the scavenging of 2,2-diphenyl-1-picrylhydrazyl (DPPH) (IC<sub>50</sub>: 4.26 ± 0.22 μg/mL) and 2 -2′-Azino-di-[3-ethylbenzthiazoline sulfonate (ABTS) radicals (IC<sub>50</sub>: 4.62 ± 0.14 μg/mL), chelating iron (IC<sub>50</sub>: 1.82 ± 0.01 μg/mL, 3.50 ± 0.09 μg/mL), and nitric oxide (IC<sub>50</sub>: 9.97 ± 0.88 μg/mL, 9.09 ± 0.11 μg/mL). The methanolic stem extracts of <italic>S. piriei</italic> possess antimicrobial activity against <italic>Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Vibrio fluvialis,</italic> and <italic>Enterococcus avium</italic>, with minimum inhibitory concentration (MIC) values ranging from 0.16 to 0.625 mg/mL, and a minimum bactericidal concentration (MBC) of 1.25 to 5 mg/mL. Cytotoxic effects of the extracts from the two plant species were also demonstrated. <italic>Sarcophyte piriei</italic> possesses therapeutic potential as evidenced by the inhibitory effects of the aqueous rhizome extract on edema (1,000 mg/kg) and prostaglandin synthesis (IC<sub>50</sub> = 0.2 mg/mL). In addition, diinsininol and diinsinin were isolated from <italic>S. sanguinea</italic> inhibited prostaglandin synthesis (IC<sub>50</sub>: 9.20 µM, 13.14 µM) and platelet-activating factor-induced exocytosis. Therefore, based on this review, further scientific research is needed to demystify the links between traditional medicinal uses, various secondary metabolites, and the pharmacology of the two plants.</p>